US · Healthcare

Abcellera Biologics Inc (ABCL)

Biotechnology

Abcellera Biologics Inc (ABCL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ABCL

P/E ratio

25.00

Abcellera Biologics Inc (ABCL) — FAQ

What is ABCL's P/E ratio?

The price-to-earnings (P/E) ratio for Abcellera Biologics Inc (ABCL) is 25.00 (data as of 2026-05-24).

Does Abcellera Biologics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Abcellera Biologics Inc (ABCL). Check the MyAverix Finance app for the latest dividend data.

What sector is Abcellera Biologics Inc in?

Abcellera Biologics Inc (ABCL) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ABCL listed on?

ABCL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)